Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation

Figure 11

RMSDCa graphic of pramipexole, pramipexole mannose adduct, and pramipexole ribose adduct in dopamine receptor D3. (a) 50 ns trajectories and (b) 5 ns trajectories.

(a)

(b)